Specialty Pharma Journal Specialty, Precision & Technology
MAINZ, Germany & NEW YORK–(BUSINESS WIRE)–BioNTech AG, a rapidly growing biotechnology company focused on precise immunotherapies for the treatment of cancer and infectious disease, today announced that it has entered into a multi-year research and development (R&D) collaboration with Pfizer Inc. (NYSE: PFE) to develop mRNA-based vaccines for prevention of …
Tag Archives: BioNTech
August, 2018
September, 2016
-
21 September
BioNTech Enters $310 Million Personalized Cancer Vaccine Deal with Genentech
MAINZ, Germany, September 21, 2016 /PRNewswire/ –BioNTech AG, a fully integrated private biotechnology company developing personalized cancer immunotherapies, today announced that it will enter into a worldwide strategic collaboration with Genentech, a member of the Roche Group, to develop, manufacture and commercialize novel messenger RNA (mRNA)-based, individualized cancer vaccines. The …
November, 2015
-
3 November
Sanofi and BioNTech Enter an Up to $1.58 Billion Immuno-Oncology Partnership
PARIS and MAINZ, Germany, November 3, 2015 /PRNewswire via COMTEX/ — Sanofi and BioNTech A.G. today announced that they have entered into a multiyear exclusive collaboration and license agreement. This research collaboration between Sanofi and BioNTech will leverage the scientific expertise of the two organizations to discover and develop up to …
May, 2015
-
12 May
Lilly Enters Research Deal with BioNTech for New Cancer Immunotherapies
Pharma giant Eli Lilly and Company is teaming up with Germany-based BioNTech to discover novel cancer immunotherapies. The companies have entered into a research collaboration to discover new cancer drugs, which use the body’s own immune system to attack cancer cells and create possible new treatment options for patients with …